GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
- B5226 NeurotensinSummary: NTR1 activator
- B5228 [D-Phe12]-BombesinSummary: Bombesin receptor antagonist
- B5229 Kinetensin (human)Summary: Endogenous neurotensin-like peptide
- B5230 LitorinSummary: Amphibian bombesin-like peptide
- B5231 Neuromedin U (rat)Summary: Endogenous peptide regulating blood pressure
- B5232 Secretin (rat)Summary: Gastrointestinal peptide that stimulates pancreatic and biliary secretion
- B5234 [D-Lys3]-GHRP-61 CitationTarget: ghrelin receptorSummary: ghrelin receptor antagonist
- B5238 Neuropeptide AF (human)Summary: Endogenous antiopioid peptide implicated in pain modulation and endocrine functions
- B5242 L-670,596Summary: thromboxane A2/prostaglandin endoperoxide receptor antagonist
- B5248 JMV 449Summary: metabolically stable neurotensin receptor agonist peptide